Conditional expression of MCM7 increases tumor growth without altering DNA replication activity  by Yoshida, Kenichi & Inoue, Ituro
Conditional expression of MCM7 increases tumor growth without
altering DNA replication activity
Kenichi Yoshida, Ituro Inoue
Genetic Diagnosis, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan
Received 30 July 2003; accepted 2 September 2003
First published online 19 September 2003
Edited by Julio Celis
Abstract The minichromosome maintenance (MCM) 2^7 com-
plex is a putative DNA helicase complex that facilitates the
initiation of DNA replication. Here, we generated a cell line
MCM7+/^/MCM7-FLAG, in which one allele of MCM7 is mu-
tated whereas a tetracycline-repressible promoter could manip-
ulate the expression of exogenous MCM7 protein. Overex-
pressed MCM7 protein supports e⁄cient DNA replication of
Epstein^Barr virus oriP and rapid formation of tumors in
nude mice without altering the activity of cellular DNA repli-
cation. This system provides a unique setting for studying the
function of MCM7 and for screening for potential therapeutics
for malignant tumors.
1 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
Key words: MCM7; DNA replication;
Homologous recombination;
Tetracycline-repressible promoter; Tumor growth
1. Introduction
Minichromosome maintenance protein (MCM) is com-
posed of six structurally related subunits (MCM2^7) and is
essential for eukaryotic DNA replication initiation and the
early stage of the elongation process [1^5]. MCM proteins
are members of the AAA+ (ATPases associated with a variety
of cellular activities) family of proteins [6]. The DNA-depen-
dent ATPase motifs, including both Walker A and B motifs,
are highly conserved in the central region of MCM proteins
from yeast to mammalian cells suggesting its crucial roles in
the functions of MCM [7]. Although helicase activity with all
six MCM subunits has remained elusive, a subassembly of
MCM, the MCM4/6/7 double trimeric complex, possesses
DNA helicase activity as a presumed replicative helicase at
replication forks in eukaryotic cells [8^13].
Recently it has been shown that MCM proteins are more
frequently detected in cells from malignant tissues than in
those from normal tissues, suggesting that MCM proteins
could be a good indicator of cancer cells [14]. Immunohisto-
chemical studies in a variety of tissues demonstrate the in-
creased expression of MCM7 in solid tumors and premalig-
nant proliferative states [15]. In this study, we directly assessed
the in vivo role of MCM7 in human cells by genetic ap-
proaches capable of manipulating MCM7 protein level. Our
results clearly showed that enhanced MCM7 protein induced
the acceleration of oriP-dependent Epstein^Barr virus (EBV)
replication and tumor mass formation whereas the activity of
cellular DNA replication was not changed. This is a ¢rst ex-
perimental link between MCM7 and malignant cell prolifer-
ation.
2. Materials and methods
2.1. MCM7 targeting construct and screening for recombinants
A BAC clone (RP11-506M12; accession number AC073842) con-
taining the human MCM7 gene was used as the source for homolo-
gous arms. The two polymerase chain reaction (PCR)-ampli¢ed frag-
ments, 2.2 kb and 3.8 kb subclone, containing the region immediately
5P and 3P of KS (the highly conserved Lys387 and Ser388 residues in the
Walker A motif located in exon 9), were assembled in the pKO plas-
mid (Stratagene) surrounding a promoterless neomycin (Neo)-resis-
tant gene containing simian virus 40 polyadenylation signals (Neo-
poly(A)) (Fig. 1A). G418-resistant clones were screened by PCR
(Fig. 1B). The oligonucleotides 5P-cccaagcttgtgagtggttagagaacaatgg-
caa-3P (M-4), 5P-caatggccgatcccattaataacttcgt-3P (7-1), 5P-ggcatgctggg-
gatgcggtataacttcg-3P (7-2), and 5P-cagtggaacgaggtcaggggacacccttgt-3P
(M-21) were used as primers.
2.2. Construction of inducible cell lines
Tetracycline-inducible FLAG-tagged MCM7 cell lines were pro-
duced using the Tet-o¡ system (Clontech). pTet-O¡ (Clontech) in
which the original Neo marker is replaced by a puromycin (Puro)-
resistant gene was used. After Puro selection, the integrity and func-
tioning of pTet-O¡ was veri¢ed by luciferase reporter assay using
pTRE2hyg-Luc (Clontech). A FLAG tag was fused to the 3P-end of
the human MCM7 cDNA coding region by PCR. The ampli¢ed frag-
ment was inserted downstream of the tetO-CMV minimal promoter of
pTRE2hyg (Clontech). The resulting plasmid expresses MCM7-
FLAG protein under the control of tetR-VP16 [16]. After transfection
and selection with hygromycin B, desirable clones were tested by
Western blot using anti-FLAG antibody. Tet system approved fetal
bovine serum (Clontech) was used.
2.3. Cell culture and transfections
HCT116 cells and their derivatives were cultured in McCoy’s 5A
medium (Invitrogen) containing 10% (v/v) fetal bovine serum (Hy-
clone) and antibiotics (penicillin and streptomycin) at 37‡C under
5% CO2. Cells were transfected with Lipofectamine Plus (Invitrogen)
according to the manufacturer’s instruction. Stable transformants
were selected with each drug at the following concentrations: 400
Wg/ml Geneticin (Invitrogen), 1 Wg/ml Puro (Invitrogen), and 100
Wg/ml hygromycin B (Invitrogen).
2.4. Cell proliferation and cell cycle analysis
Cells were counted after trypan blue treatment. DNA replication
activity was measured by bromodeoxyuridine (BrdU) incorporation
0014-5793 / 03 / $22.00 L 2003 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
doi:10.1016/S0014-5793(03)01018-4
*Corresponding author. Fax: (81)-3-5449 5764.
E-mail address: yoshidak@ims.u-tokyo.ac.jp (K. Yoshida).
Abbreviations: EBV, Epstein^Barr virus; Dox, doxycycline; MCM,
minichromosome maintenance; Neo, neomycin; Puro, puromycin;
SDS^PAGE, sodium dodecyl sulfate^polyacrylamide gel electropho-
resis
FEBS 27667 26-9-03
FEBS 27667 FEBS Letters 553 (2003) 213^217
into newly synthesized DNA using Cell Proliferation ELISA (Roche).
BrdU labeling was conducted by adding BrdU to the tissue culture
medium before harvest for a period of 2 h.
2.5. Antibodies, Western blot analysis, and chromatin fraction
preparation
Anti-human MCM7, anti-human ORC2, anti-human MCM3 (San-
ta Cruz Biotechnology), anti-neomycin phosphotransferase II (Up-
state), anti-FLAG M2 monoclonal antibody-peroxidase conjugate
(Sigma), horseradish peroxidase-conjugated anti-mouse, anti-rabbit,
and anti-goat IgG antibodies (Amersham Biosciences) were pur-
chased. Cells were lysed in RIPA lysis bu¡er and Western blotting
and immunoprecipitation were performed as described before [17].
For preparation of the chromatin fraction, cells were treated prior
to lysis as described [18]. For quantifying immunoblotting, Scion Im-
age 4.02 software (http://www.scioncorp.com) was used.
2.6. Assay for viral plasmid replication
Cells (2.5U105 per 35-mm dish) were transfected with a plasmid (1
Wg), then washed extensively 1 day after transfection and 10% of the
cells were returned to culture. Forty-eight hours after transfection,
zeocin (400 Wg/ml) was added and cells were selected for up to 2
weeks. Colonies were stained by crystal violet. The plasmid, pCEP4
(Invitrogen), contains the minimal replicator of EBV oriP and the
EBNA-1 gene. The hygromycin-resistant gene was replaced by a zeo-
cin-resistant gene derived from pcDNA3.1/Zeo (Invitrogen).
2.7. Tumorigenicity in nude mice
Cells were harvested before inoculation and resuspended in serum-
free medium at a concentration of 1.5U107 cells/ml. Cells (3U106
cells in 0.2 ml) were then inoculated s.c. at the proximal dorsal mid-
line into 4-week-old female athymic BALB/c-nu/nu mice (Japan Clea).
Tumor volumes were calculated with the formula LUW2, where L is
length and W is width. Mice were housed in barrier environments,
with food and water with or without doxycycline (Dox; 2 Wg/ml)
provided ad libitum.
3. Results and discussion
3.1. MCM7 heterozygous cells
To examine the cellular roles of MCM7 in human cells, we
¢rst attempted to minimize the endogenous MCM7 protein
level. The targeting vector was designed to create a non-func-
tional allele by replacing the KS amino acids (Lys387 and
Ser388 residues) located within the Walker A motif with the
Neo-resistant gene by homologous recombination (Fig. 1A).
Fig. 1. MCM7 heterozygous HCT116 cells. A: Schematic of the human MCM7 gene locus and gene targeting strategy. The positions of exons
(E) 1^14 of the human MCM7 gene are indicated as closed boxes. The Neo-resistant gene with poly(A) is indicated as an open box. Primers
used for PCR screening are indicated. Recombination between the targeting vector and endogenous locus deletes the conserved lysine (K) and
serine (S) of the Walker A motif G(X)5KS located in exon 9. A schematic representation of wild-type protein and C-terminally Neo-fused
MCM7 protein is shown on the right side. Characteristic zinc-¢nger motif and helicase domain are indicated. B: Genomic DNA prepared from
a parental +/+ clone and from a +/3 clone was subjected to PCR with primer pairs shown in A. Gel electrophoresis and ethidium bromide
stain to visualize the PCR products. C: Western blot analysis of total cell lysates using anti-MCM7 (left) and anti-Neo phosphotransferase II
(right) antibody. Total cell lysates of +/+, pcDNA3/Neo-transfected +/+ cells (+/+(Neo)), and +/3 cells loaded per lane. Note the wild-type
Neo was detected as a 32 kDa protein. The positions of MCM7 and MCM7-Neo chimeric protein are also indicated. D: Western blots analysis
of the chromatin fraction prepared from +/+ and +/3 cells using anti-MCM7 (upper) and anti-Neo (lower) antibody.
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The heterozygous clone (+/3) was identi¢ed by PCR screen-
ing in human colon cancer cells HCT116. For the 5P and 3P
homologous regions, primer set M-4 and 7-1 produces a 2.3-
kb and primer set 7-2 and M-21 produces a 3.9-kb product
from the mutated allele (Fig. 1B). Western blot experiments
revealed that the heterozygous clone (+/3) produced C-termi-
nally Neo-fused protein (MCM7-Neo) along with wild-type
protein, they have too close molecular weights to separate
them (Fig. 1C). As a control, wild-type Neo protein transi-
ently transfected into wild-type cells was detected by anti-Neo
antibody as a 32-kDa protein (Fig. 1C, right panel). Chroma-
tin fractions recovered from +/+ and +/3 cells showed that
both cells contained equal amounts of MCM7 protein (Fig.
1D, upper panel). There was no appearance of MCM7-Neo
protein in the chromatin fraction of +/3 cells (Fig. 1D, lower
panel).
To determine whether one copy of MCM7 is su⁄cient to
confer the initiation of DNA replication in HCT116 cells, cell
growth and BrdU incorporation were measured. Cell prolifer-
ation rate and DNA replication activity were not changed
(data not shown). These results are not surprising, because
MCM proteins are 100^1000-fold more abundant than the
estimated number of origins in Saccharomyces cerevisiae and
mammalian cells [18^23].
Fig. 2. Dox-regulated MCM7-FLAG expression in MCM7þ=3HCT116 cells. A: MCM7þ=3/MCM7-FLAG cells were grown in medium con-
taining 2 Wg/ml of Dox for the time period indicated at the top. Lysates of independent clones (H14 and H15) and wild-type cells (WT) were
resolved by sodium dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^PAGE) and subjected to Western blotting using an anti-FLAG
antibody. MCM7-FLAG protein and non-speci¢c (NS) band are indicated. Histograms of a representative blot are calculated (Scion Image
Beta 4.02) and shown below. As loading controls, anti-p53 and MCM3 antibodies were used (bottom panel). B: Cells were treated with Dox
at a concentration indicated at the top for 30 h. Lysates were resolved by SDS^PAGE and subjected to Western blotting using an anti-FLAG
antibody. As a loading control, anti-ORC2 antibody was used (bottom panel). C: Cell proliferation rate of MCM7þ=3/MCM7-FLAG cells
treated with (+) or without (3) Dox. Means and standard deviation of four measurements are indicated. D: BrdU incorporation of
MCM7þ=3/MCM7-FLAG cells treated with (+) or without (3) Dox. Comparison of BrdU incorporation of asynchronous cells growing 2 h in
culture, with the incorporation in +/+ cells held at 1. Means and standard deviation of four measurements are indicated. E: Western blot anal-
ysis of the chromatin fraction prepared from MCM7þ=3/MCM7-FLAG cells treated with (+) or without (3) Dox for 30 h. Chromatin frac-
tions were directly subjected to immunoblotting (IB) using anti-MCM7 (upper) and anti-FLAG (middle) antibodies, or immunoprecipitation
(IP) using anti-FLAG antibody, and then subjected to IB using anti-MCM3 (lower) antibody. F: MCM7 increases the DNA replication from
oriP of EBV. Establishment of drug-resistant colonies of MCM7þ=3/MCM7-FLAG cells after transfection of pCEP4/Zeo treated with (+) or
without (3) Dox. Following selection with zeocin for up to 2 weeks, colonies were visualized by staining with crystal violet. Histograms of a
representative colony blot are calculated (Scion Image Beta 4.02) and shown at the bottom. Asterisk represents statistical signi¢cance
(P6 0.01). Means and standard deviation of four measurements are shown.
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3.2. Conditional MCM7 expression
To establish a cell line in which the exogenous MCM7
protein level is tightly regulated, we transfected ¢rst the tetra-
cycline transactivator regulator protein expression vector and
next the tetracycline-regulatable MCM7-FLAG expression
vector, in which the expression of MCM7-FLAG could be
shut o¡ by Dox treatment. We used MCM7+/3 cells because
of their lower background of endogenous MCM7 protein
than wild-type cells. We then tested the e¡ect of the Dox
treatment on MCM7-FLAG expression in MCM7þ=3/
MCM7-FLAG cells. To follow the depletion of MCM7-
FLAG, cell samples were taken at time points 0, 6, 24, and
30 h, after cells were split and placed in fresh medium con-
taining 2 Wg/ml of Dox, and analyzed by Western blotting
with an anti-FLAG antibody (Fig. 2A). Upon addition of
Dox, MCM7-FLAG protein levels decreased, and after 24 h
the protein level of MCM7-FLAG was equal to the basal level
of wild-type cells. Wild-type cells have no FLAG-tagged pro-
tein indicating the band seen in the same position of MCM7-
FLAG is a non-speci¢c signal (Fig. 2A). p53 and MCM3
remained unchanged at all time points (Fig. 2A). We also
checked the MCM7-FLAG level after 30 h of treatment in
culture medium containing di¡erent concentrations of Dox
(Fig. 2B). Cell culture in medium containing 1 ng/ml Dox
was su⁄cient to shut o¡ the expression of MCM7-FLAG
(Fig. 2B). ORC2 was consistently detected at all Dox concen-
trations (Fig. 2B).
To determine the e¡ect of overexpressed MCM7 on cell
growth and DNA replication, we compared the number of
live cells and BrdU incorporation of MCM7þ=3/MCM7-
FLAG cells in the presence or absence of Dox. No di¡erence
in growth rate and DNA replication activity was seen with or
without Dox treatment (Fig. 2C,D). We then tested the func-
tionality of MCM7-FLAG protein. Western blots of the chro-
matin fraction of MCM7þ=3/MCM7-FLAG cells treated with
or without Dox showed equal amounts of MCM7 loaded on
the chromatin fraction (Fig. 2E, upper panel). Speci¢c chro-
matin loading of MCM7-FLAG was observed in the Dox-
untreated MCM7þ=3/MCM7-FLAG cells and the functional-
ity of this protein was further characterized by its co-immu-
noprecipitation with MCM3 protein (Fig. 2E, middle and
lower panels).
3.3. Increased MCM7 expression supports the acceleration of
EBV oriP-dependent DNA replication and tumor
proliferation
A possible involvement of MCM proteins in the DNA rep-
lication from oriP of EBV has been recently documented
[24,25]. Therefore, MCM7þ=3/MCM7-FLAG cells are a suit-
able assay system to check whether the DNA replication from
Fig. 2 (Continued).
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oriP of EBV is dependent on a cellular licensing factor. A
plasmid carrying oriP, EBNA-1 and a zeocin resistance gene
(pCEP4/Zeo) was transfected into MCM7þ=3/MCM7-FLAG
cells treated with or without Dox and the transfected cells
were selected in zeocin for up to 2 weeks (Fig. 2F). Replica-
tion of pCEP4/Zeo allowed robust zeocin-resistant colonies to
emerge in the Dox-untreated cells but a relatively small num-
ber of zeocin-resistant colonies was seen in the Dox-treated
cells. pcDNA3.1/Zeo, a mammalian expression vector, pro-
duced almost the same number of colonies with or without
Dox (data not shown). Since episomes contain only one origin
of replication while chromosomes contain multiple origins, it
is likely that viral episomes would be far more sensitive to the
MCM7 protein level.
By global gene expression analysis, MCM7 expression was
detected at high levels in metastatic colorectal cancers but at
lower levels in non-metastatic tumors [26]. We, therefore, ex-
amined whether the presence or absence of Dox had any e¡ect
on tumorigenesis. MCM7þ=3/MCM7-FLAG cells were in-
jected s.c. and grown as xenografts in nude mice for up to 3
weeks. There was an increase in tumor establishment of the
Dox-untreated cells compared with Dox-treated cells (Fig.
3A). To check whether the regulation of MCM7-FLAG ex-
pression is maintained in xenografts, we performed immuno-
blotting using recovered tumors. We could observe that the
expression of MCM7-FLAG protein was still regulated in
xenografts (Fig. 3B). ORC2, a loading control, was equally
detected. Taken together, these results indicate the increased
expression level of MCM7 is responsible for the tumor growth
as well as EBV oriP replication. This cell line should provide a
unique system for the characterization of MCM7 function and
for screening for potential therapeutic drugs for malignant
tumors.
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Fig. 3. Increased expression of MCM7 supports e⁄cient tumorige-
nicity. A: Growth curves of MCM7þ=3/MCM7-FLAG cells treated
with (+) or without (3) Dox xenografts in nude mice. The Dox (+)
mice were maintained on 2 mg Dox/ml water for the duration of
the experiments. Error bars represent the standard deviation (n=4
mice per group). B: Western blot analysis of xenograft lysates
treated with (+) or without (3) Dox using anti-FLAG and anti-
ORC2 antibodies.
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